EC-THP Versus TCbHP in HER2-positive Lymph Node Positive Early Breast Cancer

Clinical trial NCT05883852 · RECRUITING

Trial details

NCT number: NCT05883852
Sponsor: Fudan University
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

HER2 Positive Early Breast Cancer

Start date: 2023-06-07
Primary completion: 2031-07-01
Enrollment: 1406

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.